Meet the SBMT President

SBMT President’s Message It is an incredible honor to serve as the President of the Society for Brain Mapping and Therapeutics (SBMT) Annual Meeting in Los Angeles from February 28- March 2, 2025. SBMT is a truly unique organization where scientists from various backgrounds converge on the unified goal of advancing the neurosciences.  The theme of this year’s meeting will focus on the convergence of human consciousness and neuroscientific innovation. The new era of brain-computer interface, artificial intelligence, nanotechnology, and robotics will completely change the landscape of healthcare.  The incredible stories of human perseverance, deep, thoughtful experiments and revolutionary therapies ultimately come from a source that is deep and personal to everyone.  It is that passion and drive that forces us to unlock our real potential for healing humanity.  The discoveries yet to unfold lie in a much deeper realm of consciousness, and we hope you will tap into that curiosity at our meeting, where the cutting edge of neuro innovation thrives. Our collective consciousness promotes diversity, curiosity, and humility to engage with the next great discovery to help humanity.  Our mission at SBMT is to travel the road less traveled and encourage cross-pollination between science, technology and human consciousness.  That realm of consciousness is where an idea to transform humanity exists, and I hope you will bring this excitement to our meeting. The 2025 SBMT meeting will have incredible speakers meant to challenge what you know, help you embrace the unknown, and leave you energized about the future.  By unlocking your imagination and curiosity, we hope to leave you as better scientists and deep thinkers for advancing the greater good of helping our patients. I truly look forward to seeing you. Warmest WishesAbilash Haridas, MD, FAANS, FCNS, FABPNSNeurosurgeon22nd President SBMTLos Angeles, California

Deborah Zelinsky

Her global reputation is due, in part, to her discovery of the use of eyeglasses to alter sound location and subsequent development of the Z-Bell Test℠.   The patented test allows Dr. Zelinsky and her team to prescribe lenses and use other optometric interventions that balance processing of central and peripheral eyesight, while synchronizing the integration between auditory and retinal sensory systems. The Mind-Eye Institute was created with the objective to make new science discoveries pertaining to eyes more accessible to patients both domestically and globally. Dr. Zelinsky’s vision is to train other eyecare professionals on enhancement of retinal processing using her patented methods, with a short-term goal to have accredited doctors practicing in most major population centers globally. The 20/20 eye testing standard is over 150 years old and does not consider the peripheral processing or auditory integration both of which are critical.  Dr. Zelinsky is pioneering a campaign to “Leave 20/20 in the 20th Century” and shift into a more updated assessment protocol including moving targets and overall awareness of surroundings.  Using brain mapping of the retina (which is comprised of brain tissue) the optometric profession can perform brain, rather than eye, examinations.  Patients needing this updated testing include those who have been diagnosed with a brain that isn’t functioning at its full potential.  This includes a wide range of issues, including genetic mutations, autism, attention problems such as ADD and ADHD, dyslexia, learning problems, concussions, and stroke among others. In addition to her work with the Mind-Eye Institute, Dr. Zelinsky is a fellow in both the College of Optometrists in Vision Development and the Neuro-Optometric Rehabilitation Association.  She is a board member of the Society for Brain Mapping and a community leader for the Society of Neuroscience. More on Deborah Zelinsky: Here